World Health Organization. (2019). ICD-10: International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva: WHO.
[2]
Fletcher, C.D.M., et al. (2020). WHO Classification of Tumours of Soft Tissue and Bone. 5th Edition. Lyon: IARC Press.
[3]
National Comprehensive Cancer Network. (2023). NCCN Guidelines: Soft Tissue Sarcoma. Version 2.2023.
[4]
Gupta, R., et al. (2021). Retroperitoneal Tumors: A Comprehensive Review. Journal of Clinical Oncology, 39(2), 123-135.
[5]
Wang, J., et al. (2022). Management of Uncertain Behavior Neoplasms of the Retroperitoneum. Annals of Surgical Oncology, 29(8), 5123-5135.
[6]
Casali, P.G., et al. (2020). Soft Tissue and Visceral Sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines. Annals of Oncology, 31(5), 603-617.
[7]
Perry, K.D., et al. (2021). Imaging of Retroperitoneal Tumors. Radiologic Clinics of North America, 59(4), 645-665.
[8]
Rå æ¯: Indonesian Ministry of Health. (2022). Guidelines for Cancer Management in Indonesia. Jakarta: Kemenkes RI.